Left Ventricular Longitudinal Myocardial Function of Heart Failure Patients With Transition From Reduced to Preserved

Shun Nagai1, Makoto Nishimori1,2, Masayuki Kintsu1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan.

Circulation Reports
|May 13, 2024
PubMed

Insights

Left ventricular longitudinal myocardial function, measured by global longitudinal strain (GLS), is crucial for heart failure (HF) patients. Poorer GLS in HF with preserved ejection fraction (HFpEF) patients indicates higher cardiovascular event risk, even with normal ejection fraction.

Area of Science:

  • Cardiology
  • Cardiac Physiology

Background:

  • Left ventricular (LV) longitudinal myocardial function impacts heart failure (HF) patient outcomes.
  • HF with improved ejection fraction (HFimpEF) shows better outcomes than HF with preserved ejection fraction (HFpEF).
  • LV longitudinal myocardial function in normalized ejection fraction (HFnorEF) and its link to cardiovascular events are unclear.

Purpose of the Study:

  • To compare LV longitudinal myocardial function between HFpEF and HFnorEF patients.
  • To determine the association of LV longitudinal myocardial function with cardiovascular events in HF patients with normalized ejection fraction.

Main Methods:

  • Assessed LV longitudinal myocardial function using global longitudinal strain (GLS).
  • Studied 70 HFpEF patients and 65 HFnorEF patients.
  • Followed patients for a primary endpoint of cardiovascular death or HF hospitalization over 5.6±3.1 years.

Main Results:

  • HFpEF patients had significantly lower GLS than HFnorEF patients (13.6±3.5% vs. 14.8±2.2%, P=0.02), despite similar LVEF.
  • GLS was independently associated with cardiovascular events in multivariate Cox analysis.
  • Patients with GLS >15.0% experienced fewer cardiovascular events (log-rank P=0.014).

Conclusions:

  • LV longitudinal myocardial dysfunction is more prevalent in HFpEF than HFnorEF, even with similar LVEF.
  • GLS is an independent predictor of cardiovascular events in HF patients with current LVEF ≥50%.